Plonmarlimab, a GM-CSF-neutralizing antibody, for macrophage activation syndrome.

Wang J, Wang R, Wang Q, Wu L, Tan W, Teng J, Xu K, Yin D, Meng Y, Chen X, Fu Q, Wang Z

Open source

DOI
10.1186/s13045-026-01859-7
Published
2026 Oct 28
Container
Journal of hematology & oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13045-026-01859-7,
  title = {Plonmarlimab, a GM-CSF-neutralizing antibody, for macrophage activation syndrome.},
  author = {Wang J and Wang R and Wang Q and Wu L and Tan W and Teng J and Xu K and Yin D and Meng Y and Chen X and Fu Q and Wang Z},
  year = {2026},
  journal = {Journal of hematology \& oncology},
  doi = {10.1186/s13045-026-01859-7},
  url = {https://doi.org/10.1186/s13045-026-01859-7}
}

RIS

TY  - JOUR
TI  - Plonmarlimab, a GM-CSF-neutralizing antibody, for macrophage activation syndrome.
AU  - Wang J
AU  - Wang R
AU  - Wang Q
AU  - Wu L
AU  - Tan W
AU  - Teng J
AU  - Xu K
AU  - Yin D
AU  - Meng Y
AU  - Chen X
AU  - Fu Q
AU  - Wang Z
PY  - 2026
JO  - Journal of hematology & oncology
DO  - 10.1186/s13045-026-01859-7
UR  - https://doi.org/10.1186/s13045-026-01859-7
ER  - 

APA

J, W., R, W., Q, W., L, W., W, T., J, T., K, X., D, Y., Y, M., X, C., Q, F., & Z, W. (2026). Plonmarlimab, a GM-CSF-neutralizing antibody, for macrophage activation syndrome.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-026-01859-7

Source records